J. Debord

发表

[Comparative study of the toxicity of metal chlorides and a synthetic organic molluscacide, N-tritylmorpholine, in 2 fresh-water amphipods, Gammarus pulex and Echinogammarus berilloni].

M. Vincent, J. Debord, B. Pénicaut, 1986, Annales de recherches veterinaires. Annals of veterinary research.

Pharmacokinetic tools for the dose adjustment of ciclosporin in haematopoietic stem cell transplant patients.

P. Marquet, J. Debord, F. Saint‐Marcoux, 2014, British journal of clinical pharmacology.

Tacrolimus Bayesian Dose Adjustment in Pediatric Renal Transplant Recipients

P. Marquet, J. Debord, F. Saint‐Marcoux, 2020, Therapeutic drug monitoring.

Clinical Pharmacokinetics and Bayesian Estimators for the Individual Dose Adjustment of a Generic Formulation of Tacrolimus in Adult Kidney Transplant Recipients

P. Marquet, N. Picard, H. Mazouz, 2020, Clinical Pharmacokinetics.

Adaptive Control Methods for the Dose Individualisation of Anticancer Agents

P. Marquet, C. Sabot, J. Debord, 2000, Clinical pharmacokinetics.

Application of a Gamma Model of Absorption to Oral Cyclosporin

P. Marquet, Y. Meur, J. Debord, 2001, Clinical pharmacokinetics.

Development and Evaluation of a Simulation Procedure to Take Into Account Various Assays for the Bayesian Dose Adjustment of Tacrolimus

P. Marquet, L. Rostaing, N. Kamar, 2011, Therapeutic drug monitoring.

Maximum A Posteriori Bayesian Estimation of Oral Cyclosporin Pharmacokinetics in Patients with Stable Renal Transplants

P. Marquet, Y. Meur, G. Paintaud, 2002, Clinical Pharmacokinetics.

Analytical findings in a suicide involving sodium azide.

P. Marquet, J. Debord, G. Lachâtre, 1996, Journal of analytical toxicology.

Performance of the New Mycophenolate Assay Based on IMPDH Enzymatic Activity for Pharmacokinetic Investigations and Setup of Bayesian Estimators in Different Populations of Allograft Recipients

A. Prémaud, P. Marquet, Y. Lebranchu, 2009, Therapeutic drug monitoring.

A bidimensional logistic distribution for use in competitive adsorption studies

J. Bollinger, J. Debord, Michel Harel, 2019, Journal of Molecular Liquids.

Pharmacokinetic Study of Mycophenolate Mofetil in Patients with Systemic Lupus Erythematosus and Design of Bayesian Estimator Using Limited Sampling Strategies

J. Piette, P. Marquet, J. Hulot, 2008, Clinical pharmacokinetics.

Decrease of serum paraoxonase activity in chronic renal failure.

P. Marquet, T. Dantoine, C. Leroux-Robert, 1998, Journal of the American Society of Nephrology : JASN.

Paraoxonase 1 Activity: A New Vascular Marker of Dementia?

T. Dantoine, J. Debord, L. Merle, 2002, Annals of the New York Academy of Sciences.

Pharmacokinetics of propofol and its conjugates after continuous infusion in normal and in renal failure patients: a preliminary study.

N. Nathan, J. Debord, G. Lachâtre, 1993, Acta anaesthesiologica Belgica.

Fasting Status and Circadian Variation Must be Considered When Performing AUC‐based Therapeutic Drug Monitoring of Tacrolimus in Renal Transplant Recipients

A. Åsberg, S. Bergan, J. Debord, 2020, Clinical and translational science.

Pharmacogenetic—Whole blood and intracellular pharmacokinetic—Pharmacodynamic (PG-PK2-PD) relationship of tacrolimus in liver transplant recipients

F. Lemaitre, É. Bellissant, J. Debord, 2020, PloS one.

Pharmacokinetic models to assist the prescriber in choosing the best tacrolimus dose

A. Åsberg, J. Debord, F. Saint‐Marcoux, 2018, Pharmacological research.

A Limited Sampling Strategy to Estimate Exposure of Everolimus in Whole Blood and Peripheral Blood Mononuclear Cells in Renal Transplant Recipients Using Population Pharmacokinetic Modeling and Bayesian Estimators

A. Åsberg, P. Marquet, J. Debord, 2018, Clinical Pharmacokinetics.

Modeling of binary and ternary batch adsorption systems via multidimensional logistic distribution and statistical physics

A. Bonilla-Petriciolet, J. Bollinger, L. Sellaoui, 2021, Journal of Environmental Chemical Engineering.

Mirror, Mirror on the Wall, Which Is the Fairest of Them All? Comparing the Hill, Sips, Koble–Corrigan, and Liu Adsorption Isotherms

K. Chu, J. Bollinger, J. Debord, 2022, Industrial & Engineering Chemistry Research.

Comparison of 2- and 3-compartment models for the Bayesian estimation of methotrexate pharmacokinetics.

P. Marquet, C. Sabot, J. Debord, 1995, International journal of clinical pharmacology and therapeutics.

Inhibition of human serum arylesterase by metal chlorides.

J. Bollinger, T. Dantoine, J. Debord, 2003, Journal of inorganic biochemistry.

The Elovich isotherm equation: Back to the roots and new developments

K. Chu, J. Bollinger, J. Debord, 2022, Chemical Engineering Science.

Pharmacokinetics of vinorelbine in man

P. Marquet, J. Debord, G. Lachâtre, 2004, European Journal of Clinical Pharmacology.

Cholinesterase inhibition by derivatives of 2-amino-4,6-dimethylpyridine.

J. Bollinger, J. Robert, J. Debord, 1997, Journal of enzyme inhibition.

Beyond Freundlich and Langmuir: the Ruthven–virial equilibrium isotherm for aqueous-solid adsorption systems

M. Hashim, K. Chu, A. Mudhoo, 2022, Chemical Papers.

Simultaneous sorption of 4-nitrophenol and 2-nitrophenol on a hybrid geocomposite based on surfactant-modified pillared-clay and activated carbon

J. Bollinger, J. Debord, M. Baudu, 2015 .

Bayesian pharmacokinetic estimation of vinorelbine in non-small-cell lung cancer patients

P. Marquet, C. Sabot, J. Debord, 1998, European Journal of Clinical Pharmacology.

Acetylcholinesterase inhibition by two phosphoric 4-nitroanilides.

J. Bollinger, J. Debord, B. Pénicaut, 1990, Journal of enzyme inhibition.

RP-HPLC LIPOPHILICITY STUDIES FOR SOME (HETERO)ARYLAMIDES DERIVED FROM 2-AMINO 4,6-DIMETHYL PYRIDINE: INTRODUCTION OF AN HYDROGEN-BOND DESCRIPTOR

J. Bollinger, J. Robert, J. Debord, 2011 .

Effect of arsenic compounds on Vibrio fischeri light emission and butyrylcholinesterase activity

J. Bollinger, I. Villaescusa, J. Debord, 2007 .

Tungsten determination in biological fluids, hair and nails by plasma emission spectrometry in a case of severe acute intoxication in man.

P. Marquet, J. Debord, G. Lachâtre, 1997, Journal of forensic sciences.

pKa Constant Determination of Two Triazole Pesticides: Tebuconazole and Penconazole

J. Bollinger, F. Bordas, M. Komárek, 2013, Journal of Solution Chemistry.

The Role of Hyaluronidase on Lidocaine and Bupivacaine Pharmacokinetics After Peribulbar Blockade

N. Nathan, J. Debord, G. Lachâtre, 1996, Anesthesia and analgesia.

Microcalorimetric study of the inhibition of butyrylcholinesterase by paraoxon.

J. Bollinger, T. Dantoine, B. Verneuil, 2008, Analytical biochemistry.

Maximum A Posteriori Bayesian Estimation of Mycophenolic Acid Pharmacokinetics in Renal Transplant Recipients at Different Postgrafting Periods

A. Prémaud, P. Marquet, O. Toupance, 2005, Therapeutic drug monitoring.

A Double Absorption-Phase Model Adequately Describes Mycophenolic Acid Plasma Profiles in De Novo Renal Transplant Recipients Given Oral Mycophenolate Mofetil

A. Prémaud, P. Marquet, O. Toupance, 2005, Clinical pharmacokinetics.

KINETICS OF CHOLINESTERASE INHIBITION BY ORGANOPHOSPHORUS COMPOUNDS: DETERMINATION OF DISSOCIATION AND PHOSPHORYLATION CONSTANTS IN THE PRESENCE OF LOW SUBSTRATE CONCENTRATIONS

J. Debord, B. Pénicaut, M. Labadie, 1987 .

Simultaneous determination of lidocaine and bupivacaine in human plasma: application to pharmacokinetics.

P. Marquet, J. Debord, G. Lachâtre, 1997, Therapeutic drug monitoring.

Microcalorimetric study of the inhibition of butyrylcholinesterase by sodium arsenite and zinc chloride: Use of a fractal kinetic model

J. Bollinger, T. Dantoine, F. Bordas, 2013 .

The role of hyaluronidase on lidocaine and bupivacaine pharmacokinetics after peribulbar blockade.

N. Nathan, J. Debord, G. Lachâtre, 1996 .

Bayesian Forecasting of Oral Cyclosporin Pharmacokinetics in Stable Lung Transplant Recipients With and Without Cystic Fibrosis

M. Estenne, P. Marquet, J. Debord, 2003, Therapeutic drug monitoring.

Inhibition of arylesterase by aliphatic alcohols.

J. Bollinger, T. Dantoine, B. Verneuil, 1998, Chemico-biological interactions.

Population pharmacokinetics of amikacin in intensive care unit patients studied by NPEM algorithm

P. Marquet, J. Debord, G. Lachâtre, 1995, Fundamental & clinical pharmacology.

Large Scale Analysis of Routine Dose Adjustments of Mycophenolate Mofetil Based on Global Exposure in Renal Transplant Patients

A. Prémaud, P. Marquet, J. Debord, 2011, Therapeutic drug monitoring.

Tacrolimus Exposure Prediction Using Machine Learning

P. Marquet, J. Debord, J. Woillard, 2020, Clinical pharmacology and therapeutics.

A screening procedure for the determination of 13 oral anticoagulants and rodenticides.

P. Marquet, J. Debord, G. Lachâtre, 1996, Journal of analytical toxicology.

A Time-Dependent Model Describes Methotrexate Elimination and Supports Dynamic Modification of MRP2/ABCC2 Activity

P. Marquet, S. Choquet, J. Debord, 2017, Therapeutic drug monitoring.

Bayesian Estimation of Methotrexate Pharmacokinetic Parameters and Area Under the Curve in Children and Young Adults with Localised Osteosarcoma

P. Marquet, C. Sabot, J. Debord, 2002, Clinical pharmacokinetics.

Population pharmacokinetics and Bayesian estimators for intravenous mycophenolate mofetil in haematopoietic stem cell transplant patients

P. Marquet, J. Debord, J. Woillard, 2020, British journal of clinical pharmacology.

Pharmacokinetic Modelling and Development of Bayesian Estimators for Therapeutic Drug Monitoring of Mycophenolate Mofetil in Reduced-Intensity Haematopoietic Stem Cell Transplantation

P. Marquet, E. Deconinck, J. Kantelip, 2009, Clinical pharmacokinetics.

Population Pharmacokinetics and Bayesian Estimators for Refined Dose Adjustment of a New Tacrolimus Formulation in Kidney and Liver Transplant Patients

P. Marquet, J. Debord, F. Saint‐Marcoux, 2017, Clinical Pharmacokinetics.

Pharmacokinetic Modeling and Development of Bayesian Estimators in Kidney Transplant Patients Receiving the Tacrolimus Once-Daily Formulation

P. Marquet, N. Undre, J. Debord, 2010, Therapeutic drug monitoring.

Influence of sampling-time error on cyclosporine measurements nominally at 2 hours after administration.

M. Estenne, P. Marquet, C. Knoop, 2003, Clinical chemistry.

Population pharmacokinetics of amikacin in geriatric patients studied with the NPEM-2 algorithm.

P. Marquet, J. Debord, G. Lachâtre, 1997, International journal of clinical pharmacology and therapeutics.

The Flory–Huggins Isotherm and Water Contaminant Adsorption: Debunking Some Modeling Fallacies

K. Chu, J. Bollinger, H. Bashiri, 2023, Industrial & Engineering Chemistry Research.

Pharmacokinetic Study of Tacrolimus in Cystic Fibrosis and Non-Cystic Fibrosis Lung Transplant Patients and Design of Bayesian Estimators Using Limited Sampling Strategies

Pierre Marquet, Franck Saint-Marcoux, M. Estenne, 2005, Clinical pharmacokinetics.

Predicting dyadic adjustment from general and relationship-specific beliefs.

T. Krieshok, J. Debord, J. Romans, 1996, The Journal of psychology.

Population pharmacokinetic parameters for bayesian monitoring of amikacin therapy in intensive care unit patients

J. Debord, G. Lachâtre, R. Gay, 2005, European Journal of Clinical Pharmacology.

Les artisans gaulois de Villeneuve-Saint-Germain (Aisne). Structures, production, occupation du sol

J. Debord, 1993 .

Mycophenolic Acid Exposure Prediction Using Machine Learning

P. Marquet, J. Debord, J. Woillard, 2021, Clinical pharmacology and therapeutics.

Paraoxonase 1 192/55 Gene Polymorphisms in Alzheimer's Disease

M. Cogné, T. Dantoine, J. Debord, 2002, Annals of the New York Academy of Sciences.

Comment on “Population Pharmacokinetics of Mycophenolic Acid: An Update”

P. Marquet, J. Debord, J. Woillard, 2018, Clinical Pharmacokinetics.

Influence of biological variables upon pharmacokinetic parameters of intramuscular methotrexate in rheumatoid arthritis.

P. Marquet, C. Sabot, J. Debord, 1998, International journal of clinical pharmacology and therapeutics.

Yesterday, Today, and Tomorrow. Evolution of a Sleeping Beauty: The Freundlich Isotherm.

K. Chu, J. Bollinger, J. Debord, 2023, Langmuir : the ACS journal of surfaces and colloids.

Mycophenolate Mofetil Dose Adjustment in Pediatric Kidney Transplant Recipients

P. Marquet, J. Debord, F. Saint‐Marcoux, 2023, Therapeutic drug monitoring.

Machine learning algorithms to estimate everolimus exposure trained on simulated and patient pharmacokinetic profiles

P. Marquet, J. Debord, J. Woillard, 2022, CPT: pharmacometrics & systems pharmacology.

The Jovanović adsorption isotherm in water contaminant research: Unmasking spurious versions and spotlighting the real thing

J. Bollinger, J. Debord, S. Salvestrini, 2023, Chemical Engineering Science.

Correction: A modified Sips distribution for use in adsorption isotherms and in fractal kinetic studies

J. Bollinger, J. Debord, Michel Harel, 2016 .

A modified Sips distribution for use in adsorption isotherms and in fractal kinetic studies

J. Bollinger, J. Debord, Michel Harel, 2016 .

Limited sampling strategies using Bayesian estimation or multilinear regression for cyclosporin AUC0–12 monitoring in cardiac transplant recipients over the first year post-transplantation

P. Marquet, T. Dantoine, J. Debord, 2003, European Journal of Clinical Pharmacology.

Flow microcalorimetric study of butyrylcholinesterase kinetics and inhibition.

J. Bollinger, T. Dantoine, B. Verneuil, 2006, Analytical biochemistry.

Flow microcalorimetric study of enzyme reactions: Application to arylesterase from human serum

J. Bollinger, T. Dantoine, B. Verneuil, 2005 .

Progress curve analysis of enzyme reactions by flow microcalorimetry: Use of a pseudo-first order approximation

J. Bollinger, T. Dantoine, J. Debord, 2010 .

[Pharmacokinetics of epidural or intrathecal bupivacaine in elective cesarean section].

J. Debord, G. Lachâtre, P. Feiss, 1993, Annales francaises d'anesthesie et de reanimation.